Marinus Pharmaceuticals, Inc. Share Price Deutsche Boerse AG
Equities
61Y
US56854Q2003
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.31 EUR | -0.76% | -2.24% | -86.56% |
Sales 2024 * | 3.94Cr 3.68Cr 328.72Cr | Sales 2025 * | 5.82Cr 5.44Cr 485.86Cr | Capitalization | 8.05Cr 7.52Cr 672.21Cr |
---|---|---|---|---|---|
Net income 2024 * | -12Cr -11Cr -993.97Cr | Net income 2025 * | -7.8Cr -7.29Cr -651.51Cr | EV / Sales 2024 * | -1.19 x |
Net cash position 2024 * | 13Cr 12Cr 1.06TCr | Net cash position 2025 * | 5.45Cr 5.1Cr 455.48Cr | EV / Sales 2025 * | 0.45 x |
P/E ratio 2024 * |
-0.74
x | P/E ratio 2025 * |
-1.41
x | Employees | 166 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.02% |
Latest transcript on Marinus Pharmaceuticals, Inc.
1 day | -0.76% | ||
1 week | -2.24% | ||
Current month | -7.09% | ||
1 month | +7.38% | ||
3 months | -83.83% | ||
6 months | -83.21% | ||
Current year | -86.56% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Braunstein
CEO | Chief Executive Officer | 60 | 05/18/05 |
Steven Pfanstiel
DFI | Director of Finance/CFO | 51 | 12/21/12 |
Joseph Hulihan
CTO | Chief Tech/Sci/R&D Officer | 68 | 06/19/06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tim Mayleben
BRD | Director/Board Member | 63 | 01/08/01 |
Scott Braunstein
CEO | Chief Executive Officer | 60 | 05/18/05 |
Elan Ezickson
BRD | Director/Board Member | 60 | 12/19/12 |
Date | Price | Change |
---|---|---|
14/24/14 | 1.31 | -0.76% |
13/24/13 | 1.32 | -5.71% |
12/24/12 | 1.4 | +1.45% |
11/24/11 | 1.38 | +1.47% |
10/24/10 | 1.36 | +1.49% |
Delayed Quote Deutsche Boerse AG, June 14, 2024 at 11:36 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+50.70% | 79TCr | |
+41.96% | 63TCr | |
-7.15% | 35TCr | |
+18.77% | 33TCr | |
+8.79% | 30TCr | |
+18.02% | 25TCr | |
+1.27% | 22TCr | |
+11.95% | 22TCr | |
+3.68% | 16TCr |
- Stock Market
- Equities
- MRNS Stock
- 61Y Stock